Reduces Inflammation & Pain: Unlike traditional anti-inflammatories, BPC-157 reduces systemic inflammation without interfering with natural healing
When combined in the GLOW Blend, these complementary mechanisms create comprehensive support for all aspects of wound healing: GHK-Cu optimizing gene expression and collagen quality, BPC-157 driving angiogenesis and growth factor signaling, and TB-500 mobilizing cellular migration and tissue coverage essential for rapid, organized repair in laboratory models
My consultation was not rushed and my treatment options were clearly explained to me by Julie
Johnson, W., Bergfeld, W
Journal of Nutrition , 136 (6), 1636S1640S
These include: Lifestyle interventions (dietary advice, physical activity programmes) Licensed pharmacotherapy such as orlistat, or GLP-1 receptor agonists including semaglutide 2.4 mg (Wegovy, NICE TA875) or tirzepatide (Zepbound) where clinically indicated and available Referral to tier 3 or tier 4 weight management services , including bariatric surgery assessment where appropriate Information on NHS weight management services and eligibility for licensed treatments is available via the NHS website and NICE guidance